Assessment of Efficacy and Safety of PD-1 Monoclonal Antibody Combined With IL-2 and CapeOX in Neoadjuvant Therapy for Locally Advanced Rectal Cancer Prior to Surgery: A Prospective, Multi-center, Randomized Controlled Study
Clinical trial NCT06884670 · COMPLETED
Trial details
- NCT number
- NCT06884670
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-18
- Primary completion
- 2026-05-31
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.